ITMI910572A0 - Oligopeptidi eterociclici dotati di attivita' antitumorale - Google Patents

Oligopeptidi eterociclici dotati di attivita' antitumorale

Info

Publication number
ITMI910572A0
ITMI910572A0 IT91MI572A ITMI910572A ITMI910572A0 IT MI910572 A0 ITMI910572 A0 IT MI910572A0 IT 91MI572 A IT91MI572 A IT 91MI572A IT MI910572 A ITMI910572 A IT MI910572A IT MI910572 A0 ITMI910572 A0 IT MI910572A0
Authority
IT
Italy
Prior art keywords
heterociclic
oligopeptides
cancer activity
cancer
activity
Prior art date
Application number
IT91MI572A
Other languages
English (en)
Inventor
Nicola Mongelli
Alessio Roberto D
Maria Grandi
Federico Spreafico
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of ITMI910572A0 publication Critical patent/ITMI910572A0/it
Publication of ITMI910572A1 publication Critical patent/ITMI910572A1/it
Application granted granted Critical
Publication of IT1250411B publication Critical patent/IT1250411B/it

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D209/00Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04Indoles; Hydrogenated indoles
    • C07D209/30Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Quinoline Compounds (AREA)
  • Furan Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
ITMI910572A 1990-03-12 1991-03-05 Oligopeptidi eterociclici dotati di attivita' antitumorale IT1250411B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB9005529A GB2241950B (en) 1990-03-12 1990-03-12 Heterocyclic oligopeptides endowed with antitumor activity

Publications (3)

Publication Number Publication Date
ITMI910572A0 true ITMI910572A0 (it) 1991-03-05
ITMI910572A1 ITMI910572A1 (it) 1991-09-13
IT1250411B IT1250411B (it) 1995-04-07

Family

ID=10672473

Family Applications (1)

Application Number Title Priority Date Filing Date
ITMI910572A IT1250411B (it) 1990-03-12 1991-03-05 Oligopeptidi eterociclici dotati di attivita' antitumorale

Country Status (4)

Country Link
JP (1) JPH05148227A (it)
DE (1) DE4106860A1 (it)
GB (1) GB2241950B (it)
IT (1) IT1250411B (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006511562A (ja) * 2002-12-20 2006-04-06 バイエル・ヘルスケア・アクチェンゲゼルシャフト 泌尿器系疾患の処置のための置換2,5−ジアミドインドール類の使用
WO2016025692A1 (en) * 2014-08-13 2016-02-18 The Scripps Research Institute Treatment of c9ftd/als by targeting rna expanded repeat sequences

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1521471A (en) * 1974-06-05 1978-08-16 Randall & Son Ltd J Token-deposit locks

Also Published As

Publication number Publication date
DE4106860A1 (de) 1991-09-19
IT1250411B (it) 1995-04-07
JPH05148227A (ja) 1993-06-15
GB2241950A (en) 1991-09-18
GB2241950B (en) 1993-05-12
ITMI910572A1 (it) 1991-09-13
GB9005529D0 (en) 1990-05-09

Similar Documents

Publication Publication Date Title
DE68928739D1 (de) Detecteur d'humidite
ITRM930334A0 (it) Tassano ad attivita' antitumorale.
ITMI921967A0 (it) Glucani ad attivita' immunostimolante
IT8819791A0 (it) Peptidi ad attivita' farmaceutica.
IT9019446V0 (it) "fronda".
ITMI910572A0 (it) Oligopeptidi eterociclici dotati di attivita' antitumorale
IT9022047A0 (it) 13-desosso-4'-desossi-4'-iodoantracicline
ITMI932690A0 (it) Acilsulfammidi ad attivita' antitumorale
IT8819790A0 (it) Peptidi ad attivita' farmaceutica.
KR930017816U (ko) 유희용 다리
ITMI911141A0 (it) Preparato ad attivita' anticellulitica
KR950012487U (ko) 브이씨알의 케이스 구조
FR2693103B1 (fr) Meuble de stomatologue.
IT9019209A1 (it) Derivato di n-benzamido-2-metil-3-fenilpirrolidina ad attivita' antiipertensiva
IT1219429B (it) Composizioni farmaceutiche ad attivita' antiprolattinica
ITRM950413A0 (it) Secotassani dotati di attivita' antitumorale.
IT8914502V0 (it) L'amicorario
SE9001883D0 (sv) Pivaasaengen "nattugglan"
KR910016115U (ko) 디지트론의 고정구조
IT8819446V0 (it) Legapiu'
IT9046876A0 (it) 1 b65g
IT9033609V0 (it) Deumificatore d'ambiente
IT9032809V0 (it) Valigetta di utilita'
IT9032807V0 (it) Valigetta di utilita'
ITAL920011V0 (it) "le gabbie"

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970310